Results 61 to 70 of about 1,495,687 (103)

MoLEP-Co-creating a Mycobacterium leprae transmission interruption program for the Morogoro region, Tanzania. [PDF]

PLoS Negl Trop Dis
Barth-Jaeggi T, de Coulon G, Garimo I, Msaki J, Mleoh L, Kisonga R, Modali S, Panchal S, Njebele SM, Sunderji S, Mageda K, Steinmann P.   +11 more
europepmc   +1 more source

Clinical-epidemiological profile of leprosy patients undergoing retreatment at a reference center in southeastern Brazil. [PDF]

An Bras Dermatol
Bezerra GH, Ferreira Velho PEN, França AFEDC.   +2 more
europepmc   +1 more source

Challenges of the public health response to a rare case of non-autochthonous <i>Mycobacterium leprae</i>, Ireland, 2024. [PDF]

Euro Surveill
Marshall R, Horgan E, Duane H, Dillon A, Nurdin N, O'Connell S, Sadlier C, Dee A, Sheahan A, Barrett P.   +9 more
europepmc   +1 more source

A systematic review of adverse effects associated with systemic corticosteroids in the management of leprosy. [PDF]

PLoS Negl Trop Dis
Lun AI, de Barros B, Walker SL.
europepmc   +1 more source

Case Report: Nonalcoholic Hepatic Steatosis Associated with Type-2 Leprosy Reaction. [PDF]

Am J Trop Med Hyg
Araujo Orozco KL, Prada Cubillos JS, Otero Genes MJ, Serrano-Coll H, García Posada MJ.   +4 more
europepmc   +1 more source

Protocol of a comparative multicentric non inferiority clinical trial of WHO MBMDT with a new monthly chemotherapy regimen containing rifampicin, moxifloxacin and clarithromycin (RMC) on multibacillary patients from India. [PDF]

Trials
Darlong J, Nessa S, Singh I, Sengupta U, Devi R, Govindasamy K, Maximus N, Elkana V, Haldar A, Jose AM, Jayakumar S.   +10 more
europepmc   +1 more source

Unprecedented in vivo activity of telacebec against Mycobacterium leprae. [PDF]

PLoS Negl Trop Dis
Chauffour A, Cambau E, Pethe K, Veziris N, Aubry A.   +4 more
europepmc   +1 more source

Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine. [PDF]

Am J Trop Med Hyg
Matono T, Suzuki S, Mori S, Ato M.
europepmc   +1 more source

A retrospective cohort study of monthly rifampicin, ofloxacin and minocycline in the management of leprosy at the Hospital for Tropical Diseases, London, United Kingdom. [PDF]

PLoS Negl Trop Dis
Sivakumaran P, Barros B, Antonio Dias VL, Lockwood DN, Walker SL.   +4 more
europepmc   +1 more source

Leprosy in the 21st century: a comprehensive review of immunological mechanisms, diagnosis, and treatment. [PDF]

Rev Inst Med Trop Sao Paulo
Froes Junior LAR, Sotto MN, Trindade MAB.   +2 more
europepmc   +1 more source